Justin T Ernst

This inventor holds 22 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Cancer Therapeutics. Top assignees: Effector Therapeutics, Inc., Itherx Pharmaceuticals Inc., Yale University. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Justin T Ernst. Retrieved from https://idiyas.com/inventor/justin-t-ernst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 14)

% Patents Active = 68.2

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 173(Granted Patents)

Location History:

New Heaven, CT (US) (2005)
San Diego, CA (US) (2007 - 2024)

Company Filing History:

15 out of 22

Effector Therapeutics, Inc.

patents

3 out of 3

Itherx Pharmaceuticals Inc.

Lycia Therapeutics, Inc.

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

MNK Inhibitors

eIF4A Compounds

Cytokine Inhibitors

Proteomimetics

Crystalline Forms

Piperidine-Substituted

Alpha-Ketoamides

Heterocyclic Compounds

Binding Compounds

Conjugates

Dihydroindenone

Inhibitors

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747249 - EIF4A-inhibiting compounds and methods related thereto (2026-09-29),

2. 12258332 - ASGPR cell surface receptor binding compounds and conjugates (2025-03-25),

3. 11952375 - Crystalline forms of Mnk inhibitors (2024-04-09),

4. 11878015 - Piperidine-substituted Mnk inhibitors and methods related thereto (2024-01-23),

5. 11440917 - EIF4A-inhibiting compounds and methods related thereto (2022-09-13),

6. 11286268 - EIF4E-inhibiting compounds and methods (2022-03-29),

7. 11130757 - Crystalline forms of MNK inhibitors (2021-09-28),

8. 11083727 - Piperidine-substituted Mnk inhibitors and methods related thereto (2021-08-10),

9. 11014926 - Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2 (2021-05-25),

10. 10793551 - Benzimidazole-indole inhibitors of Mnk1 and Mnk2 (2020-10-06),

11. 10577378 - EIF4A-inhibiting compounds and methods related thereto (2020-03-03),

12. 10112955 - Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2 (2018-10-30),

13. 10000487 - Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers (2018-06-19),

14. 9957277 - eIF4A-inhibiting compounds and methods related thereto (2018-05-01),

15. 9814718 - MNK inhibitors and methods related thereto (2017-11-14),

Title: Justin T Ernst: Pioneering Inventor from San Diego

Introduction: Justin T Ernst is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Justin T Ernst holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Justin T Ernst has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on society.

Collaborations: Throughout his career, Justin T Ernst has collaborated with top universities, tech companies, and government agencies to bring his inventions to life, fostering a culture of innovation and progress.

Conclusion: Justin T Ernst's passion for innovation and his dedication to pushing the boundaries of what is possible make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.